Key result
Catheter ablation of right ventricular endocavitary arrhythmias achieved long-term clinical success in 89% of patients over a median follow-up of 3.6 years.
Why the study?
Right ventricular endocavitary arrhythmias remain poorly characterized.
Does catheter ablation improve clinical outcomes in patients with right ventricular endocavitary arrhythmias?
Observational (n=53)
No
Does catheter ablation improve clinical outcomes in patients with right ventricular endocavitary arrhythmias?
Catheter ablation of right ventricular endocavitary arrhythmias is highly effective, achieving long-term clinical success in 89% of patients without causing significant RV or tricuspid valve dysfunction.
May aid recognition of rare RV endocavitary arrhythmias; leaves open optimal ablation approaches pending larger studies.
BACKGROUND: Right ventricular (RV) endocavitary arrhythmias remain poorly characterized. OBJECTIVES: The purpose of this study was to define the clinical presentation, ablation outcomes, and long-term prognosis of RV endocavitary arrhythmias. METHODS: Among 3,873 patients undergoing ventricular arrhythmia ablation between 2013 and 2025, 53 (1.4%) were included (mean age 45.4 ± 16.9 years, 64% male, mean left ventricular ejection fraction 54 ± 11%). RESULTS: Forty-three (81%) had structurally normal hearts and 10 (19%) had nonischemic cardiomyopathy, including 7 with premature ventricular contraction (PVC)-mediated cardiomyopathy and 3 with idiopathic nonischemic cardiomyopathy. Ablation indications included PVCs (n = 25), PVC-triggered ventricular fibrillation (VF) (n = 20), and ventricular tachycardia (n = 8). PVC QRS duration independently predicted developing PVC-mediated cardiomyopathy (P = 0.02). PVCs-triggering VF had shorter coupling intervals (CIs) (320 [295-358] vs 440 [400-470] ms; P < 0.05) and more frequently originated at the lateral moderator band (MB) (P = 0.03), where they also had shorter CIs than medial MB PVCs (P = 0.01). Ablation targets included the MB (n = 47), anterior papillary muscle (PM) (n = 3), inferior PM (n = 2), and conus PM (n = 1). Postablation increase in sinus rhythm QRS duration (98 [84-102] to 102 [90-114] ms; P < 0.01), V1 intrinsicoid deflection (22 [18-27] to 26 [20-95] ms; P < 0.01), and new right bundle branch block (15% of patients) did not translate into RV dysfunction or worsening tricuspid valve function. Radiofrequency energy was used in 49 patients, adjunctive cryoablation in 6, and cryoablation alone in 4. At 3.6 (1.6-5.7) years follow-up, 89% achieved clinical success with reduced antiarrhythmic drug use. CONCLUSIONS: RV endocavitary arrhythmias typically occur in structurally normal hearts as focal PVCs. PVCs-triggering VF have shorter CIs and preferentially arise from the lateral MB. Ablation is effective in management.
No takes yet. Share an insight, caveat, or question.
Haq et al. (2025) conducted an observational in Right ventricular endocavitary arrhythmias (n=53). Catheter ablation was evaluated on Clinical success (defined by arrhythmia type). Catheter ablation of right ventricular endocavitary arrhythmias achieved long-term clinical success in 89% of patients over a median follow-up of 3.6 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: